Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma

Severe asthma requires at least high doses of inhaled corticosteroids (ICS) in combination with a long-acting -agonist (LABA) or systemic corticosteroids (SCS) for more than 50% of days/year to avoid loss of control, or remains uncontrolled despite the treatment described above. The diagnosis of se...

Full description

Bibliographic Details
Main Authors: Maciej Kupczyk, Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Marek Kulus, Piotr Kuna, Izabela Kupryś-Lipińska, Henryk Mazurek
Format: Article
Language:English
Published: Termedia Publishing House 2019-05-01
Series:Advances in Dermatology and Allergology
Subjects:
bronchial asthma
severe bronchial asthma
difficult-to-treat asthma
steroid-dependent asthma
biological treatment
omalizumab
mepolizumab
benralizumab
Online Access:https://www.termedia.pl/Polish-Society-of-Allergology-statement-on-the-diagnosis-and-treatment-of-severe-difficult-to-control-bronchial-asthma,7,36441,1,1.html

Internet

https://www.termedia.pl/Polish-Society-of-Allergology-statement-on-the-diagnosis-and-treatment-of-severe-difficult-to-control-bronchial-asthma,7,36441,1,1.html

Similar Items